dantrolene has been researched along with Coronary Disease in 5 studies
Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of dantrolene sodium on occlusion and reperfusion ventricular arrhythmias (VA) were studied in a canine model." | 7.67 | Effects of dantrolene sodium on occlusion and reperfusion arrhythmias in the canine heart. ( Belhassen, B; Chagnac, A; Laniado, S; Pelleg, A; Roth, A; Shargordsky, B, 1985) |
| "The effects of dantrolene sodium on occlusion and reperfusion ventricular arrhythmias (VA) were studied in a canine model." | 3.67 | Effects of dantrolene sodium on occlusion and reperfusion arrhythmias in the canine heart. ( Belhassen, B; Chagnac, A; Laniado, S; Pelleg, A; Roth, A; Shargordsky, B, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freysz, M | 1 |
| Timour, Q | 1 |
| Bernaud, C | 1 |
| Bertrix, L | 1 |
| Faucon, G | 1 |
| Adnet, P | 1 |
| Krivosic-Horber, R | 1 |
| Davidenko, J | 1 |
| Delmar, M | 1 |
| Oates, R | 1 |
| Jalife, J | 1 |
| Rubin, AS | 1 |
| Zablocki, AD | 1 |
| Pelleg, A | 1 |
| Roth, A | 1 |
| Shargordsky, B | 1 |
| Belhassen, B | 1 |
| Chagnac, A | 1 |
| Laniado, S | 1 |
1 review available for dantrolene and Coronary Disease
| Article | Year |
|---|---|
[Calcium inhibitors and anesthesia].
Topics: Analgesics; Anesthesia, General; Anesthetics; Arrhythmias, Cardiac; Brain Ischemia; Calcium Channel | 1988 |
4 other studies available for dantrolene and Coronary Disease
| Article | Year |
|---|---|
Cardiac implications of amlodipine-dantrolene combinations.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Coronary Disease; Dantrolene; Drug Interactions; Drug | 1996 |
Electrophysiological actions of dantrolene sodium in isolated sinoatrial and atrioventricular nodes and in a model of ischemia.
Topics: Action Potentials; Animals; Atrioventricular Node; Coronary Disease; Dantrolene; Electric Conductivi | 1986 |
Hyperkalemia, verapamil, and dantrolene.
Topics: Colectomy; Colonic Neoplasms; Coronary Disease; Dantrolene; Drug Interactions; Humans; Hyperkalemia; | 1987 |
Effects of dantrolene sodium on occlusion and reperfusion arrhythmias in the canine heart.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Dantrolene; | 1985 |